BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx — Drug-Free Pain Therapy Devices

Opens the Sales Market for 33+ Additional Countries FREDERICK, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK: BIEL), is pleased to announce that it has received the CE (Conformité Européenne) Mark for its ActiPatch® and RecoveryRx® Pulsed Shortwave Therapy (PSWT) medical devices. The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue … Continue Reading

BioElectronics’ ActiPatch® Therapy To Be Marketed By DonJoy® Advantage

Drug-Free Pain Relief Technology with Premium Wraps FREDERICK, Md.,  Nov. 6, 2020 /PRNewswire/ — BioElectronics Corporation (OTC PINK: BIEL),  www.bielcorp.comis pleased to announce the execution of a commercial partnership agreement with Scott Specialties Inc (SS to bring their innovative pain management devices to the retail consumer healthcare marketplace under the DonJoy® (DJO Advantage product line. This commercial … Continue Reading

BioElectronics Chairman Outlines New Direction for Company

FREDERICK, MD, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), ( today released a Chairman’s Letter to Shareholders written by Dr. Richard Staelin, the Company’s Chairman of the Board. Dear BioElectronics Shareholders : The purpose of this letter is to update you on the activities of BioElectronics Corporation over the … Continue Reading

Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation

FREDERICK, MD, June 15, 2020 (GLOBE NEWSWIRE) —  via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL),, the maker of non-invasive electroceutical devices, announced today that it has appointed Richard Staelin, Ph.D. as the Chairman of the Board following the resignation and retirement of Ms. Patricia Whelan.  “The management team at BioElectronics thanks Patricia Whelan for her … Continue Reading

BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

FREDERICK, MD- February 3, 2020 – BioElectronics Corporation (OTC PINK: BIEL),, the maker of non-invasive electroceutical devices, is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA).  This new, over-the counter marketing clearance was granted for the drug free ActiPatch® medical device, for the … Continue Reading

BioElectronics Announces New Management Team

FREDERICK, MD- November 15, 2019 – BioElectronics Corporation (OTC PINK: BIEL), is pleased to announce that after seeking legal counsel a Board of Directors, President and Chief Executive Officer have been appointed/re-affirmed. These changes follow the unexpected passing of the Company’s founder, President and CEO Mr. Andrew Whelan, in October 2019. Pursuant to Section … Continue Reading

BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly

FREDERICK, MD, Oct. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corp. (OTCPK: BIEL) is sad to announce that its founder and CEO, Andrew J. Whelan, died suddenly last night at his home in Frederick, Maryland. The BioElectronics management team will continue to manage day-to-day operations until a permanent replacement can be confirmed. Mr. … Continue Reading

BioElectronics Announces Publication of a Study of the ActiPatch® Medical Device as an Effective Long Term Treatment for Chronic Pain

FREDERICK, MD- Oct 02, 2019 – BioElectronics Corporation (OTC PINK: BIEL) , the maker of non-invasive electroceutical devices, is pleased to announce the publication of a study in the journal Pain Research and Management, titled “A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy”. The study demonstrated that users who … Continue Reading

BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug

FREDERICK, MD, Aug. 20, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL),, is pleased to announce that it has filed a 510(k), Premarket Notification application with the U.S. Food and Drug Administration (FDA). The application is to seek expanded market clearance for the drug free, over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical … Continue Reading

The Stock Day Podcast Hosts BioElectronics’ to Discuss Its New Technology To Mitigate Opioid Use

PHOENIX, AZ / ACCESSWIRE / July 10, 2019 / The Stock Day Podcast welcomed BioElectronics Corporation (BIEL) (“the Company”), a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices. Vice President of Sales, Keith Nalepka, joined Stock Day host Everett Jolly. Jolly began the interview by asking … Continue Reading